- Poster presentation
- Open Access
Across the ditch: the collective diabetic foot assessment
© Ihaka and Rome; licensee BioMed Central Ltd. 2011
- Published: 20 May 2011
- Primary Care Health
- Glycaemic Control
- Ankle Joint
- Arterial Flow
The prevalence of diabetes (DM) and its associated manifestations is higher in New Zealand Māori than New Zealand Europeans. There is no current evidence regarding podiatric clinical characteristics of Maori with diabetes. This presentation highlights findings from a group of Maori with diabetes that have foot pathology as determined by a national generic general practice review.
Fifty three patients with diabetes were recruited from two Māori Primary Health Organisations. Podiatric specific characteristics, patient demographics and general medical conditions were recorded.
Fifty three (n=53) Māori patients were recruited for this study with a median age of 54 years (IQR: 45.5 – 61.5 years). We found that Māori had a median duration of diabetes for 15 years, were obese (median body mass index 35.7) with sub-optimal glycaemic control (HbA1c >8% 42%). Podiatric specific characteristics revealed good arterial flow (IQR: Right ankle-brachial index dorsalis pedis 1.1) and a median neuropathy score of 2 (IQR 0, 4). Half the cohort displayed restriction in movement of the right ankle joint (n= 31) and first metatarsophalangeal joints (n=29). Foot education was favourable with positive benefits such as daily foot inspection (n=52). Using a modified classification tool which targets the risk factors collectively, thirty two (60%) patients were identified as requiring regular podiatry management.
A standardised evidence-based screening and assessment tool could be widely applied by primary care health podiatrists in the detection of imminent diabetes-related foot pathology and to support disease management. This collective assessment would be of particular benefit to communities, including Maori; where the incidence of diabetes and its complications is higher.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.